(Q38854760)

English

Down-regulated miR-28-5p in human hepatocellular carcinoma correlated with tumor proliferation and migration by targeting insulin-like growth factor-1 (IGF-1).

scientific article published on 10 July 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 September 2017

Down-regulated miR-28-5p in human hepatocellular carcinoma correlated with tumor proliferation and migration by targeting insulin-like growth factor-1 (IGF-1). (English)

1 reference

Europe PubMed Central

7 September 2017

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

author name string

Xiaomin Shi

1

1 reference

Europe PubMed Central

7 September 2017

Fei Teng

2

1 reference

Europe PubMed Central

7 September 2017

publication date

10 July 2015

1 reference

Europe PubMed Central

7 September 2017

Molecular and Cellular Biochemistry

1 reference

Europe PubMed Central

7 September 2017

408

1 reference

Europe PubMed Central

7 September 2017

1-2

1 reference

Europe PubMed Central

7 September 2017

283-293

1 reference

Europe PubMed Central

7 September 2017

https://scigraph.springernature.com/pub.10.1007/s11010-015-2506-z

0 references

Sorafenib for advanced hepatocellular carcinoma (HCC): impact of rationing in the United Kingdom

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2506-Z

21 January 2018

Clinical trials of note. Sorafenib as adjuvant treatment in the prevention of disease recurrence in patients with hepatocellular carcinoma (HCC) (STORM).

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2506-Z

21 January 2018

Hippo signaling regulates microprocessor and links cell-density-dependent miRNA biogenesis to cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2506-Z

21 January 2018

Downregulated miR-646 in clear cell renal carcinoma correlated with tumour metastasis by targeting the nin one binding protein (NOB1).

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2506-Z

21 January 2018

The level of circulating miRNA-10b and miRNA-373 in detecting lymph node metastasis of breast cancer: potential biomarkers

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2506-Z

21 January 2018

Insulin-like growth factor-I (IGF-I) receptor activation rescues UV-damaged cells through a p38 signaling pathway. Potential role of the IGF-I receptor in DNA repair

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2506-Z

21 January 2018

Gefitinib resistance in HCC mahlavu cells: upregulation of CD133 expression, activation of IGF-1R signaling pathway, and enhancement of IGF-1R nuclear translocation

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2506-Z

21 January 2018

Human axonal survival of motor neuron (a-SMN) protein stimulates axon growth, cell motility, C-C motif ligand 2 (CCL2), and insulin-like growth factor-1 (IGF1) production

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2506-Z

21 January 2018

Involvement of connective tissue growth factor (CTGF) in insulin-like growth factor-I (IGF1) stimulation of proliferation of a bovine mammary epithelial cell line

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2506-Z

21 January 2018

Identification of the IGF1/PI3K/NF κB/ERK gene signalling networks associated with chemotherapy resistance and treatment response in high-grade serous epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2506-Z

21 January 2018

Clinical and metabolic characteristics of acromegalic patients with high IGF1/normal GH levels during somatostatin analog treatment.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2506-Z

21 January 2018

A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2506-Z

21 January 2018

MiR-145 functions as a tumor suppressor by directly targeting histone deacetylase 2 in liver cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2506-Z

21 January 2018

Analysis of the combined action of miR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repression

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2506-Z

21 January 2018

Strand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2506-Z

21 January 2018

Systemic therapy in HCC: lessons from brivanib.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2506-Z

21 January 2018

IGF1-induced AKT phosphorylation and cell proliferation are suppressed with the increase in PTEN during luteinization in human granulosa cells.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2506-Z

21 January 2018

The miRNA-17∼92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2506-Z

21 January 2018

Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2506-Z

21 January 2018

Insulin-like growth factor-1 (IGF1) genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating IGF-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast c

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2506-Z

21 January 2018

Defining the pathway to insulin-like growth factor system targeting in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2506-Z

21 January 2018

Dual inhibition of epidermal growth factor receptor and insulin-like growth factor receptor I: reduction of angiogenesis and tumor growth in cutaneous squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2506-Z

21 January 2018

Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02).

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2506-Z

21 January 2018

A phase II pharmacodynamic study of preoperative figitumumab in patients with localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2506-Z

21 January 2018

Post-receptor IGF1 insensitivity restricted to the MAPK pathway in a Silver–Russell syndrome patient with hypomethylation at the imprinting control region on chromosome 11

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2506-Z

21 January 2018

Construction of HCC-targeting artificial miRNAs using natural miRNA precursors

1 reference

https://pubmed.ncbi.nlm.nih.gov/26160280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A lentiviral sponge for miRNA-21 diminishes aerobic glycolysis in bladder cancer T24 cells via the PTEN/PI3K/AKT/mTOR axis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26160280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specific miRNA expression profiles of non-tumor liver tissue predict a risk for recurrence of hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/26160280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence for a tumour suppressive function of IGF1-binding proteins in human breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26160280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of miRNA let-7 and its major targets in prostate cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26160280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patient

1 reference

https://pubmed.ncbi.nlm.nih.gov/26160280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26160280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clarifications on miRNA and cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26160280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11010-015-2506-Z

1 reference

Europe PubMed Central

7 September 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

7 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38854760&oldid=1505269468"